Doxazosin mesylate
Tocris Bioscience, part of Bio-Techne | Catalog # 2964
α1 antagonist
Key Product Details
Description
α1 antagonist
Alternative Names
UK 33274
Product Description
Doxazosin mesylate is a selective α1-adrenoceptor antagonist (pKi values are 9.0, 8.5 and 8.4 for human α1B, α1A and α1D receptors respectively). Displays antihypertensive activity.Scientific Data Images for Doxazosin mesylate
Reduced viability of differentiated cardiomyocytes exposed to cardiotoxic small molecules.
The viability of differentiated cardiomyocytes was assessed using a Resazurin metabolism assay. A) Untreated cells metabolize Resazurin (Catalog # AR002) to produce resorufin, a fluorescent molecule that can be measured using a fluorometric plate reader. Resorufin fluorescence accumulated in untreated cardiomyocytes. Cells treated with the cardiotoxic small molecules Staurosporine (blue; Catalog # 1285), a non-selective protein kinase inhibitor, or Doxazosin (tan; Catalog # 2964), an alpha1 antagonist, did not metabolize Resazurin, as shown by lack of fluorescence accumulation, indicating a loss of viability upon treatment. B) Cell morphology of untreated, Staurosporine-treated, and Doxazosin-treated cardiomyocytes was assessed by brightfield microscopy.Product Specifications
Molecular Weight
547.58
Formula
C23H25N5O5.CH3SO3H
Storage
Desiccate at RT
Purity
≥98% (HPLC)
Chemical Name
4-Amino-2-[4-(1,4-benzodioxan-2-carbonyl)piperazin-1-yl]-6,7-dimethoxyquinazoline methanesulfonate
CAS Number
77883-43-3
PubChem ID
62978
InChI Key
VJECBOKJABCYMF-UHFFFAOYSA-N
SMILES
NC2=NC(N3CCN(C(C4COC(C=CC=C5)=C5O4)=O)CC3)=NC1=CC(OC)=C(OC)C=C12.CS(=O)(O)=O
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 41.07 | 75 |
Preparing Stock Solutions
for Doxazosin mesylate
The following data is based on the product molecular weight 547.58
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.75 mM | 2.43 mL | 12.17 mL | 24.35 mL |
| 3.75 mM | 0.49 mL | 2.43 mL | 4.87 mL |
| 7.5 mM | 0.24 mL | 1.22 mL | 2.43 mL |
| 37.5 mM | 0.05 mL | 0.24 mL | 0.49 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Kenny Evaluation of the pharmacological selectivity profile of α1 adrenoceptor antagonists at prostatic α1 adrenoceptors: binding functional and in vivo studies. Br.J.Pharmacol. 1996 PMID: 8799556
- Ma Chiral selective effects of doxa. enantiomers on blood pressure and urinaruy bladder pressure in anesthetized rats. Acta Pharmacol.Sinica 2006 PMID: 17049117
- Alabaster and Davey The α1-adrenoceptor antagonist profile of doxazosin: preclinical pharmacology. Br.J.Clin.Pharmacol. 1986 PMID: 2871857
Product Specific Notices for Doxazosin mesylate
For research use only
Loading...
Loading...
Loading...